EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Sialylation of IgE reduces FcεRIα interaction and mast cell and basophil activation in vitro and increases IgE half‐life in vivo

Lara Dühring iD, Janina Petry, Gina-Maria Lilienthal, Yannic C Bartsch, Marie Kubiak, Clarissa Pfeufer, Selina Lehrian, Jana S Buhre, Hanna B Lunding, Carsten Kern, Jochen Behrends iD, Theresa Walsemann und 8 weitere

Allergy · 2023

DOI: 10.1111/all.15665 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Allergy, 2023. Verfasst von Lara Dühring und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratories of Immunology and Antibody Glycan Analysis, Institute of Nutritional Medicine, University of Lübeck and University Hospital Schleswig-Ho…. Hauptthemen laut MEDLINE: Basophils, Mast Cells. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Volkswagen Foundation, Deutsche Zentrum für Lungenforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To the Editor, Immunoglobulin E (IgE) plays a crucial role in allergic reactions, including systemic anaphylaxis, by binding to the highaffinity IgE receptor FcεRI (FcεRIα + FcεRIβ + FcεRIγ) on mast cells and basophils and, upon allergenmediated aggregation, inducing the release of inflammatory mediators.1– 3 The allergic potential of IgE antibodies (Abs) is further affected by IgE glycosylationdependent interactions with membranebound and soluble carbohydratebinding proteins (e.g., galectins, siglecs, and Ctype lectin receptors) as well as different structural features (E14).1,3 Many healthy individuals harbor allergenspecific IgE Abs in the absence of an allergic disease (E5, E6), suggesting qualitative differences in IgEtriggered responses. Similarly, not all allergic individuals develop severe disease forms (e.g., asthma), and it is still unclear why allergen immunotherapy (AIT) is effective in some individuals but not in all (E6). Different natural or AITinduced inflammatory states of the specific Tand Bcell response may lead, as described for IgG (E7),4 to differently glycosylated IgE Abs that contribute distinctly to the induction of allergic responses. IgE Abs have several conserved Nglycosylation sites in the constant region of their heavy chains. Most of them are of the complex type and potentially galactosylated and terminal sialylated2,5 (Figure 1A,B). By comparing the effects of sialylated versus enzymatically desialylated IgE monoclonal (m)Abs, a recent study suggested that highly sialylated IgE Abs have a stronger potential to induce allergic reactions than lower sialylated IgE Abs.6 Notably, this observation is opposite to the findings that sialylation dampens the inflammatory potential of IgG, IgA, and IgM Abs (E8E10).4,7 Here, we further investigated the role of IgE sialylation on FcεRIα interaction, mast cell and basophil loading and activation, and IgEmediated passive systemic anaphylaxis (PSA) in mice. Therefore, we generated an antiTNP (2,4,6trinitrophenol) murine IgE mAb with three different sialylation levels: (i) originally sialylated (originally sial; glycosylation form generated by the hybridoma cell line), (ii) enzymatically desialylated (desial), and (iii) enzymatically additional sialylated (high sial) (Figure 1B– D). Both enzymatic IgE glycan modifications did not influence antigen binding (Figure 1E). Desialylated antiTNP IgE mAbs showed a stronger interaction with human and murine FcεRIα than originally sialylated and additionally sialylated IgE mAbs, whereas the latter two sialylated IgE glycoforms showed a comparable low or no interaction with FcεRIα in these assays, respectively (Figure 1F). This observation was unexpected due to the mentioned findings about the lower allergic potential of desialylated compared to sialylated IgE Abs6 but is in line with a stronger interaction of desialylated IgG Abs with Fcγ receptors than sialylated IgG Abs (E8). A comparable trend was observed when human mast cells differentiated from CD34+ blood cells were activated with the three antiTNP IgE glycoforms and TNPOVA as antigen (Figure S1). Moreover, less sialylated antiTNP IgE mAbs showed an enhanced loading on the human mast cell line LAD2 as well as on human blood basophils, which correlated positively with their activation (Figure 1G– J and Figure S1). Low sensitivity of the FcεRIα interaction assay and of the differentiated human mast cell assay and/or additional factors to FcεRIα binding might explain the higher loading and activation potentials of originally sialylated (orig. sial) compared to additional sialylated (high sial) IgE Abs in the LAD2 mast cell and blood basophil assays. Together, these data suggest that the higher interaction of de−/less sialylated IgE with mast cells and basophils correlate with their stronger activation potential. Next, we compared the potential of the three antiTNP IgE mAb glycoforms in an IgEmediated passive systemic anaphylaxis (PSA) mouse model (Figure 2A and Figure S1). In accordance with the data described by Shade et al., 20206 but in contrast to the expectation based on our in vitro data, intravenous (i.v.) injection of desialylated antiTNP IgE mAbs, followed by i.v. injection of TNPcoupled ovalbumin (TNPOVA) as “allergen” 6 or 24 h later, hardly induced any anaphylaxis, as measured by the drop in body core/rectal temperature, compared to the sialylated IgE mAbs (Figure 2B and Figure S1). However, we realized that desialylated antiTNP IgE mAbs could neither be detected in serum nor on blood basophils already 6 h after injection (Figure 2C,D and Figure S1). These data suggested a highly reduced serum halflife of desialylated IgE mAbs, which has also been described for desialylated IgA Abs in an asialoglycoprotein receptordependent manner (E11). To counteract the potential quick clearance of desialylated IgE mAbs, we blocked asialoglycoprotein receptors with an excess of desialylated (asialo)α1acid glycoprotein (AGP; orosomucoid) (E11) before sensitizing mice with the antiTNP IgE glycoforms (Figure 2E

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BasophilsMast CellsHumansHalf-LifeImmunoglobulin EReceptors, IgE

Substanzen

Immunoglobulin EReceptors, IgE

Autor:innen und Institutionen

  • Laboratories of Immunology and Antibody Glycan Analysis, Institute of Nutritional Medicine, University of Lübeck and University Hospital Schleswig-Holstein, Airway Research Center North (ARCN), German Center for Lung Re…
  • Core Facility Fluorescence Cytometry, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
  • Division of Clinical and Molecular Allergology, Priority Area Chronic Lung Diseases, Research Center Borstel, Leibniz Lung Center, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Borstel, Ger…
  • Fraunhofer Institute of Toxicology and Experimental Medicine, German Center for Lung Research (DZL), Hannover, Germany.
  • Department of Human Medicine, Medical School Berlin, Berlin, Germany.
  • Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Healt…

ORCID-Profile: Lara Dühring, Jochen Behrends, Susann Dehmel, Uta Jappe, Johann Rahmöller, Marc Ehlers

Förderung

  • Deutsche Forschungsgemeinschaft
  • Volkswagen Foundation
  • Deutsche Zentrum für Lungenforschung

Zitieren

APA

Dühring, L., Petry, J., Lilienthal, G. M., Bartsch, Y. C., Kubiak, M., Pfeufer, C., Lehrian, S., Buhre, J. S., Lunding, H. B., Kern, C., Behrends, J., Walsemann, T., Gädert, L., Sommer, C., Krüger, L., Blanchard, V., Dehmel, S., Jappe, U., Rahmöller, J., & Ehlers, M. (2023). Sialylation of IgE reduces FcεRIα interaction and mast cell and basophil activation in vitro and increases IgE half‐life in vivo. Allergy. https://doi.org/10.1111/all.15665

Vancouver

Dühring L, Petry J, Lilienthal GM, Bartsch YC, Kubiak M, Pfeufer C, et al. Sialylation of IgE reduces FcεRIα interaction and mast cell and basophil activation in vitro and increases IgE half‐life in vivo. Allergy. 2023. doi:10.1111/all.15665

BibTeX
@article{Dhring2023,
  author = {Dühring, Lara and Petry, Janina and Lilienthal, Gina-Maria and Bartsch, Yannic C and Kubiak, Marie and Pfeufer, Clarissa and Lehrian, Selina and Buhre, Jana S and Lunding, Hanna B and Kern, Carsten and Behrends, Jochen and Walsemann, Theresa and Gädert, Leonie and Sommer, Charline and Krüger, Lynn and Blanchard, Véronique and Dehmel, Susann and Jappe, Uta and Rahmöller, Johann and Ehlers, Marc},
  title = {Sialylation of IgE reduces FcεRIα interaction and mast cell and basophil activation in vitro and increases IgE half‐life in vivo},
  journal = {Allergy},
  year = {2023},
  doi = {10.1111/all.15665}
}
Kostenlos starten →